Günther Loidl
Chief Tech/Sci/R&D Officer bij BACHEM HOLDING AG
Vermogen: 1 M $ op 31-03-2024
Actieve functies van Günther Loidl
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BACHEM HOLDING AG | Chief Tech/Sci/R&D Officer | 01-01-2015 | - |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Director/Board Member | 01-01-2000 | - |
Loopbaan van Günther Loidl
Opleiding van Günther Loidl
| Max Planck Institute of Biochemistry | Doctorate Degree |
Statistieken
Internationaal
| Zwitserland | 3 |
| Duitsland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
- Beurs
- Insiders
- Günther Loidl
- Ervaring
